Robotic surgical companion market projected to reach $13.07 billion by 2030

The robotic surgical companion market is forecast to grow from $6.9 billion in 2025 to $13.07 billion by 2030, driven by demand for minimally invasive surgery, rising cancer cases, and AI-enabled surgical support. North America held the largest share in 2025, while the report points to broader adoption across major global regions.

Why it matters: - Robotic surgical companions are becoming a bigger part of operating rooms as hospitals look for more precision, better dexterity and faster recovery times. - The market’s projected climb to $13.07 billion by 2030 signals continued investment in surgical automation and decision support. - Rising cancer incidence is increasing demand for highly precise, minimally invasive procedures that can limit damage to healthy tissue.

What happened: - The Business Research Company published a 2026 outlook for the robotic surgical companion market. - The report values the market at $6.9 billion in 2025 and projects $7.86 billion in 2026. - The report forecasts the market will reach $13.07 billion by 2030, reflecting a 13.5% CAGR over the forecast period. - North America held the largest regional share in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The company offered a free sample report and a full report through its website.

The details: - Robotic surgical companions assist surgeons during operations with greater precision, improved dexterity and real-time guidance. - These systems are designed to reduce risks and complications while simplifying complex tasks. - The report links prior market growth to a shortage of skilled surgeons, rising procedure complexity, demand for minimally invasive techniques, advances in robotics and higher hospital spending on surgical equipment. - Future growth drivers include AI-enabled surgical assistance, wider robotic surgery training, more outpatient procedures, a stronger focus on patient recovery and better imaging integration. - The report highlights precision-assisted surgery, minimally invasive robotic techniques, surgeon guidance and decision support, improved dexterity technologies and streamlined operating room workflows as key trends. - The World Health Organization said in February 2024 that new cancer cases worldwide are expected to surpass 35 million by 2050, up 77% from about 20 million in 2022. - The report says cancer growth is a major driver because robotic systems help support precise surgery with less damage to healthy tissue. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The forecast suggests robotic surgical support is shifting from a niche capability toward a broader surgical platform tied to efficiency, training and patient outcomes. - The emphasis on AI, imaging and workflow tools points to a market competing on integration, not just robotic hardware. - Cancer care remains one of the clearest demand drivers because it rewards precision and minimally invasive methods.

What's next: - The market is expected to keep expanding as hospitals adopt more robotic assistance and outpatient surgery volumes rise. - The report points to stronger adoption of AI-enabled guidance and training programs as a likely next phase. - Regional competition may broaden as markets outside North America build out robotic surgery capacity.

The bottom line: - Robotic surgical companions are moving into a growth phase powered by cancer care demand, surgical precision and AI-assisted workflows.